Ticker
HUMACompany Name
HUMACYTE INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Cash and Equivalents | Total Debt | Enterprise Value | Market Capitalization |
---|---|---|---|---|
6/30/2025 | $ 88.24M | $ 83.66M | $ 271.78M | $ 276.36M |
3/31/2025 | $ 113.06M | $ 82.21M | $ 237.51M | $ 268.36M |
12/31/2024 | $ 95.15M | $ 79.89M | $ 249.22M | $ 264.48M |
9/30/2024 | $ 70.78M | $ 79.38M | $ 736.07M | $ 727.47M |
6/30/2024 | $ 93.56M | $ 78M | $ 778.12M | $ 793.68M |
3/31/2024 | $ 115.5M | $ 76.53M | $ 613.6M | $ 652.58M |
12/31/2023 | $ 80.45M | $ 57.51M | $ 347.41M | $ 370.35M |
9/30/2023 | $ 99.99M | $ 56.78M | $ 185.69M | $ 228.9M |
6/30/2023 | $ 114.6M | $ 56.32M | $ 359.59M | $ 417.88M |
3/31/2023 | $ 129.57M | $ 50.52M | $ 331.16M | $ 410.22M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Market Cap + Debt - CashnEq
(=) EV
EV for HUMACYTE INC is calculated as follows: Market Cap [ $ 127.26M ] + Debt [ $ 89.08K ] - CashnEq [ $ 1.32M ]
(=) EV [ $ 126.04M ]
Minimum
Sep 30, 2020
Maximum
Jun 30, 2021
Average
Median
filtered constituents | 3.33K |
---|---|
min | $ -1.69B |
max | $ 6.81B |
average | $ 1.25B |
median | $ 438.06M |
std | $ 1.66B |